CARL:NASDAQ
Carlsmed Inc
$13.92
arrow_downward
-1.83%(-0.26) 1D
Sep 29, 12:04:58 PM GMT-4 · USD
search
All symbols
No data
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CARL...
Open
$14.14
High
$14.21
Low
$13.88
Mkt. cap
380.05M
Avg. vol.
121.00K
Volume
8.67K
52-wk high
$17.23
52-wk low
$8.50
EPS
-$1.44
Shares outstanding
27.30M
No. of employees
127
Open
$14.14
High
$14.21
Low
$13.88
Mkt. cap
380.05M
Avg. vol.
121.00K
Volume
8.67K
52-wk high
$17.23
52-wk low
$8.50
EPS
-$1.44
Shares outstanding
27.30M
No. of employees
127
News stories
From web sources and news partners
www.marketscreener.com
·
22 hours ago
Carlsmed, Inc. Reaffirms Revenue Guidance for the Full Year 2026
TradingView
·
1 day ago
Carlsmed appoints new CFO, reaffirms 2026 revenue outlook
www.marketscreener.com
·
1 day ago
Carlsmed Appoints Richard Heppenstall as Chief Financial Officer
About Carlsmed Inc
CEO-
Employees127
Founded2018
HeadquartersCarlsbad, California, United States
SectorMedical device
Websitecarlsmed.com
Analyst ratings
Based on 5 analysts giving stock ratings to CARL in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for CARL in the last 3 months.
Highest
Current $13.92
$23.00 (+65.23%)
Average
$19.33 (+38.86%)
Lowest
$17.00 (+22.13%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Ryan Zimmerman BTIG | Buy | Maintained | $23.00 | +65.2% | 09/28/2026 |
Richard Newitter Truist Financial | Buy | Reiterated | - | - | 09/29/2026 |
Travis Steed Bank of America Securities | Buy | Maintained | - | - | 08/13/2026 |
Matthew O'Brien Piper Sandler | Buy | Reiterated | $18.00 | +29.3% | 08/06/2026 |
David Saxon Needham | Buy | Reiterated | $17.00 | +22.1% | 08/06/2026 |
David Roman Goldman Sachs | Buy | Maintained | $16.00 | +14.9% | 05/05/2026 |
Last report
Aug 5, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.39 / -$0.47
+17.02%beat
arrow_upward
Revenue / Est. (USD)
18.94M / 17.80M
+6.40%beat
arrow_upward
Fiscal Q2 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 13.07M | 15.16M | 16.12M | 18.94M |
Cost of goods sold | 3.15M | 3.56M | 3.69M | 4.40M |
Cost of revenue | 3.15M | 3.56M | 3.69M | 4.40M |
Research and development expenses | 4.44M | 5.26M | 5.18M | 6.04M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 14.52M | 15.66M | 16.52M | 19.54M |
Operating expense | 18.96M | 20.93M | 21.70M | 25.58M |
Total operating expenses | 22.11M | 24.48M | 25.39M | 29.98M |
Operating income | -9.04M | -9.32M | -9.28M | -11.04M |
Other non operating income | -65.00K | 7.00K | - | - |
EBT including unusual items | -8.53M | -8.61M | -8.70M | -10.51M |
EBT excluding unusual items | -8.53M | -8.61M | -8.70M | -10.51M |
Income tax expense | - | - | - | - |
Effective tax rate | - | - | - | - |
Other operating expenses | - | - | - | - |
Net income | -8.53M | -8.61M | -8.70M | -10.51M |
Net profit margin | -65.21% | -56.80% | -53.96% | -55.49% |
Earnings per share | -0.37 | -0.29 | -0.26 | -0.39 |
Interest and investment income | 954.00K | 1.03M | 891.00K | 839.00K |
Interest expense | -380.00K | -330.00K | -311.00K | -313.00K |
Net interest expenses | 574.00K | 698.00K | 580.00K | 526.00K |
Depreciation and amortization charges | - | - | - | - |
EBITDA | -8.95M | -9.22M | -9.18M | -10.91M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1